GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.300 $0.440 Thursday, 18th Apr 2024 GLMD stock ended at $0.379. This is 2.80% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $0.365 to a day high of $0.379.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
2023-09-13 $0.770 $0.782 $0.750 $0.751 30 171
2023-09-12 $0.81 $0.81 $0.770 $0.800 9 198
2023-09-11 $0.83 $0.83 $0.793 $0.81 12 316
2023-09-08 $0.790 $0.81 $0.790 $0.81 8 434
2023-09-07 $0.81 $0.81 $0.785 $0.81 10 328
2023-09-06 $0.83 $0.83 $0.80 $0.80 3 839
2023-09-05 $0.90 $0.90 $0.81 $0.81 29 780
2023-09-01 $0.82 $0.89 $0.790 $0.89 87 973
2023-08-31 $0.82 $0.82 $0.80 $0.81 11 185
2023-08-30 $0.82 $0.82 $0.795 $0.81 12 872
2023-08-29 $0.780 $0.82 $0.770 $0.81 18 745
2023-08-28 $0.780 $0.83 $0.765 $0.81 12 735
2023-08-25 $0.789 $0.83 $0.750 $0.772 39 522
2023-08-24 $0.82 $0.84 $0.786 $0.80 21 534
2023-08-23 $0.86 $0.87 $0.82 $0.84 16 105
2023-08-22 $0.89 $0.89 $0.795 $0.85 18 216
2023-08-21 $0.787 $0.90 $0.780 $0.88 29 999
2023-08-18 $0.81 $0.81 $0.770 $0.80 19 514
2023-08-17 $0.778 $0.84 $0.771 $0.784 28 735
2023-08-16 $0.84 $0.85 $0.770 $0.771 62 530
2023-08-15 $0.85 $0.88 $0.81 $0.81 39 832
2023-08-14 $0.88 $0.90 $0.84 $0.85 37 776
2023-08-11 $0.83 $0.87 $0.82 $0.84 34 583
2023-08-10 $0.89 $0.93 $0.80 $0.85 113 671
2023-08-09 $0.93 $0.96 $0.88 $0.91 79 774
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT